CausalSentinel

Protein Dossier — PROC (Vitamin K-dependent protein C)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: deep venous thrombosis (dvt) 0.191 0.0297 1.27e-10 Wald ratio 1 trans NA
Height 0.0334 0.00585 1.10e-08 Wald ratio 1 trans NA
Diagnoses - main ICD10: I80 Phlebitis and thrombophlebitis 0.249 0.0581 1.84e-05 Wald ratio 1 trans NA
Coronary heart disease -0.0725 0.0173 2.92e-05 Wald ratio 1 trans NA
Myocardial infarction -0.0739 0.0192 1.13e-04 Wald ratio 1 trans NA
Creatinine (enzymatic) in urine -0.0186 0.00485 1.27e-04 Wald ratio 1 trans NA
Body mass index (BMI) -0.0193 0.00507 1.37e-04 Wald ratio 1 trans NA
Non-cancer illness code self-reported: pulmonary embolism (with or without) dvt 0.171 0.0474 3.03e-04 Wald ratio 1 trans NA
Diagnoses - main ICD10: M72 Fibroblastic disorders 0.194 0.057 6.86e-04 Wald ratio 1 trans NA
Heel bone mineral density (BMD) T-score automated -0.0222 0.00657 7.19e-04 Wald ratio 1 trans NA
Sodium in urine -0.0135 0.00499 0.00669 Wald ratio 1 trans NA
Potassium in urine -0.0138 0.00515 0.00737 Wald ratio 1 trans NA
…and 114 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2961_1_2 Protein C Suhre K 2019
prot-c-3758_68_3 Activated Protein C Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

27 association rows across 13 traits (26 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating PROC levels 1e-254 rs1799809 4 GCST90860431 no MR -> candidate analysis
PROC protein levels 1e-245 rs1799810 5 GCST90470335 no MR -> candidate analysis
F9/PROC protein level ratio 2e-231 rs1799810 1 GCST90314748 no MR -> candidate analysis
Protein C levels 2e-42 rs1799810 2 GCST006119 no MR -> candidate analysis
Height 4e-41 rs7599210 1 GCST90245848 MR: beta=0.0334, p=1.10e-08 (trans)
Vitamin K-dependent protein C levels 8e-32 rs1799810 3 GCST90250174 no MR -> candidate analysis
Venous thromboembolism 7e-29 rs1158867 2 GCST90244158 no MR -> candidate analysis
Serum levels of protein PROC 2e-22 rs1799809 2 GCST90088150 no MR -> candidate analysis
Encounter for long-term (current) use of anticoagulants (Phe 4e-19 rs200045749 2 GCST90479975 no MR -> candidate analysis
Blood protein levels 5e-13 rs2069901 2 GCST006585 no MR -> candidate analysis
Coagulation defects (PheCode 286) 2e-11 rs200045749 1 GCST90479980 no MR -> candidate analysis
Takes medication for blood clot/ pulmonary embolism/ deep ve 3e-11 rs200045749 1 GCST90479548 no MR -> candidate analysis
…and 1 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 423 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
hereditary thrombophilia due to congenital protein C deficiency 0.929 established (curated) no MR -> candidate analysis
venous thromboembolism 0.921 0.938 multi-layer: burden+GWAS (allelic-series candidate) no MR -> candidate analysis
deep vein thrombosis 0.937 0.97 multi-layer: burden+GWAS (allelic-series candidate) no MR -> candidate analysis
thrombophilia due to protein C deficiency, autosomal dominant 0.943 established (curated) no MR -> candidate analysis
protein c deficiency 0.813 established (curated) no MR -> candidate analysis
thrombophilia due to protein C deficiency, autosomal recessive 0.919 established (curated) no MR -> candidate analysis
phlebitis 0.855 0.978 multi-layer: burden+GWAS (allelic-series candidate) MR: beta=0.249, p=1.84e-05 (trans)
Thrombophlebitis 0.85 0.971 multi-layer: burden+GWAS (allelic-series candidate) MR: beta=0.249, p=1.84e-05 (trans)
Abnormal thrombosis 0.829 0.896 established (curated) no MR -> candidate analysis
thrombophilia 0.829 0.829 exploratory rare-variant signal no MR -> candidate analysis
blood coagulation disease 0.667 0.628 multi-layer: burden+GWAS (allelic-series candidate) no MR -> candidate analysis
Portal vein thrombosis 0.883 0.883 exploratory rare-variant signal no MR -> candidate analysis
Thromboembolism 0.675 established (curated) no MR -> candidate analysis
hereditary disease 0.759 established (curated) no MR -> candidate analysis
heart disorder 0.709 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 13 have no MR estimate in this resource. Across all retrieved diseases for this gene: 6 exploratory rare-variant signal(s), 6 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 2 known modulators (Vitamin K-dependent protein C)
gnomAD constraint pLI=7.3e-05, LOEUF=0.865 — LoF-tolerant
GWAS Catalog 31 unique SNPs / 62 rows
ClinVar 510 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx 1 clinical annotations across 1 drugs

Caveats declared by the tools

Sources

Provenance